nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

01.04.2013 | Original Paper

Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study

verfasst von: Kai G. Kahl, Wiebke Greggersen, Ulrich Schweiger, Joachim Cordes, Christoph U. Correll, Helge Frieling, Chakrapani Balijepalli, Christian Lösch, Susanne Moebus

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Metabolic syndrome (MetS) is an important risk factor for the development of type-2 diabetes and coronary artery disease. We aimed to compare the MetS prevalence in patients with borderline personality disorder (BPD) with comparison subjects followed in primary care from a similar region. One hundred and thirty-five BPD patients according to DSM-IV diagnostic criteria were compared to 1009 subjects from primary care. We used the American Heart Association/National Heart, Lung and Blood Institute criteria to determine the rate of MetS. The age-standardized prevalence of MetS was more than double in patients with BPD compared to comparison subjects (23.3 vs. 10.6 %, p < 0.05). Regarding individual MetS criteria, hyperglycemia was significantly more prevalent in both genders (p < 0.05). Abdominal obesity (p < 0.05) and hypertriglyceridemia (p < 0.05) were significantly higher only in women with BPD. Within BPD patients, an increased rate of MetS was associated with higher BMI (p = 0.004), age (p = 0.03), treatment with second-generation antipsychotics (quetiapine, olanzapine and clozapine; p = 0.032), dysthymia (p = 0.031), panic disorder (p = 0.032), benzodiazepine dependency (p = 0.015) and binge eating disorder p = 0.02). Our results demonstrate an increased MetS rate, dysregulated glucose and lipid metabolism in patients with BPD. Cardiometabolic monitoring and careful screening for physical health conditions among people with BPD is warranted.

Boehm G, Racoosin JA, Laughren TP, Katz R (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27:596–601CrossRef

Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith RC, Burg MM, Cornell C, Saab PG, Kaufmann PG, Czajkowski SM, Jaffe AS (2004) Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study. Psychosom Med 66:466–474PubMedCrossRef

Cooper SJ (2005) Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes. Appetite 44:133–150PubMedCrossRef

Cuppett M, Latin RW (2002) A survey of physical activity levels of certified athletic trainers. J Athl Train 37:281–285PubMed

De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Moller HJ (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European psychiatric association (EPA), supported by the European association for the study of diabetes (EASD) and the European society of cardiology (ESC). Eur Psychiatry 24:412–424PubMedCrossRef

De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, Newcomer JW, Uwakwe R, Asai I, Moller HJ, Gautam S, Detraux J, Correll CU (2011) Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 10:138–151PubMed

De Hert M, Detraux J, van Winkel R, Yu W, Correll CU (2011) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8:114–126PubMedCrossRef

De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Moller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10:52–77

de Jonge P, Honig A, van Melle JP, Schene AH, Kuyper AM, Tulner D, Schins A, Ormel J (2007) Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 164:1371–1378PubMedCrossRef

10.

Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 375:181–183CrossRef

11.

El-Gabalawy R, Katz LY, Sareen J (2010) Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosom Med

12.

Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ (2005) Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for pennsylvanians. Bipolar Disord 7:424–430PubMedCrossRef

13.

Fogelholm M (2010) Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A systematic review. Obes Rev 11:202–221PubMedCrossRef

14.

Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 287:356–359PubMedCrossRef

15.

Frankenburg FR, Zanarini MC (2004) The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry 65:1660–1665PubMedCrossRef

16.

Friedman M, Rosenman RH (1959) Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. J Am Med Assoc 169:1286–1296PubMedCrossRef

17.

Glassman AH, Bigger JT Jr, Gaffney M (2009) Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 66:1022–1029PubMedCrossRef

18.

Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP (2004) Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 65:948–958PubMedCrossRef

19.

Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, Smith SM, Dawson DA, Pulay AJ, Pickering RP, Ruan WJ (2008) Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 69:533–545PubMedCrossRef

20.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef

21.

Haney M, Comer SD, Fischman MW, Foltin RW (1997) Alprazolam increases food intake in humans. Psychopharmacology (Berl) 132:311–314CrossRef

22.

Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M (2006) Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosom Med 68:213–216PubMedCrossRef

23.

Hudson JI, Lalonde JK, Coit CE, Tsuang MT, McElroy SL, Crow SJ, Bulik CM, Hudson MS, Yanovski JA, Rosenthal NR, Pope HG Jr (2010) Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder. Am J Clin Nutr 91:1568–1573PubMedCrossRef

24.

Hybels CF, Pieper CF, Blazer DG, Steffens DC (2008) The course of depressive symptoms in older adults with comorbid major depression and dysthymia. Am J Geriatr Psychiatry 16:300–309PubMedCrossRef

25.

Jackson HJ, Burgess PM (2004) Personality disorders in the community: results from the Australian National Survey of Mental Health and Well-being Part III. Relationships between specific type of personality disorder, Axis 1 mental disorders and physical conditions with disability and health consultations. Soc Psychiatry Psychiatr Epidemiol 39:765–776PubMed

26.

Kahl KG, Bester M, Greggersen W, Rudolf S, Dibbelt L, Stoeckelhuber BM, Gehl HB, Sipos V, Hohagen F, Schweiger U (2005) Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder. Psychosom Med 67:407–412PubMedCrossRef

27.

Kahl KG, Bens S, Ziegler K, Rudolf S, Dibbelt L, Kordon A, Schweiger U (2006) Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder. Biol Psychiatry 59:667–671PubMedCrossRef

28.

Kahl KG, Bens S, Ziegler K, Rudolf S, Kordon A, Dibbelt L, Schweiger U (2009) Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuroendocrinology 34:353–357PubMedCrossRef

29.

Kahl KG, Greggersen W, Schweiger U, Cordes J, Balijepalli C, Losch C, Moebus S (2011) Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci [epub ahead of print]

30.

Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617–627PubMedCrossRef

31.

Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP (2004) Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 66:316–322PubMedCrossRef

32.

Lee HB, Bienvenu OJ, Cho SJ, Ramsey CM, Bandeen-Roche K, Eaton WW, Nestadt G (2010) Personality disorders and traits as predictors of incident cardiovascular disease: findings from the 23-year follow-up of the Baltimore ECA study. Psychosomatics 51:289–296PubMed

33.

Lieb K, Rexhausen JE, Kahl KG, Schweiger U, Philipsen A, Hellhammer DH, Bohus M (2004) Increased diurnal salivary cortisol in women with borderline personality disorder. J Psychiatr Res 38:559–565PubMedCrossRef

34.

Martinez JM, Garakani A, Kaufmann H, Aaronson CJ, Gorman JM (2010) Heart rate and blood pressure changes during autonomic nervous system challenge in panic disorder patients. Psychosom Med 72:442–449PubMedCrossRef

35.

Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M (2011) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders–a systematic review and meta-analysis. Schizophr Bull [epub ahead of print]

36.

Moebus S, Hanisch JU, Neuhauser M, Aidelsburger P, Wasem J, Jockel KH (2006) Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices. Ger Med Sci 4:Doc07PubMed

37.

Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jockel KH (2007) Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 6:22PubMedCrossRef

38.

Moran P, Stewart R, Brugha T, Bebbington P, Bhugra D, Jenkins R, Coid JW (2007) Personality disorder and cardiovascular disease: results from a national household survey. J Clin Psychiatry 68:69–74PubMedCrossRef

39.

Nabi H, Kivimaki M, Zins M, Elovainio M, Consoli SM, Cordier S, Ducimetiere P, Goldberg M, Singh-Manoux A (2008) Does personality predict mortality? Results from the GAZEL French prospective cohort study. Int J Epidemiol 37:386–396PubMedCrossRef

40.

Nakashita Y, Nakamura M, Kitamura A, Kiyama M, Ishikawa Y, Mikami H (2010) Relationships of cigarette smoking and alcohol consumption to metabolic syndrome in Japanese men. J Epidemiol 20:391–397PubMedCrossRef

41.

Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roque IFM, Richter B, Mauricio D (2008) Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev CD003054

42.

Patel JK, Buckley PF, Woolson S, Hamer RM, McEvoy JP, Perkins DO, Lieberman JA, Investigators C (2009) Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. Schizophr Res 111:9–16PubMedCrossRef

43.

Pfaltz MC, Grossman P, Michael T, Margraf J, Wilhelm FH (2010) Physical activity and respiratory behavior in daily life of patients with panic disorder and healthy controls. Int J Psychophysiol 78:42–49

44.

Purnell JQ, Kahn SE, Samuels MH, Brandon D, Loriaux DL, Brunzell JD (2009) Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab 296:E351–E357PubMedCrossRef

45.

Rafanelli C, Milaneschi Y, Roncuzzi R, Pancaldi LG (2010) Dysthymia before myocardial infarction as a cardiac risk factor at 2.5-year follow-up. Psychosomatics 51:8–13PubMed

46.

Raikkonen K, Matthews KA, Kuller LH (2002) The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 51:1573–1577PubMedCrossRef

47.

Richter N, Juckel G, Assion HJ (2010) Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psychiatry Clin Neurosci 260:41–49PubMedCrossRef

48.

Schweiger U, Greggersen W, Rudolf S, Pusch M, Menzel T, Winn S, Hassfurth J, Fassbinder E, Kahl KG, Oltmanns KM, Hohagen F, Peters A (2008) Disturbed glucose disposal in patients with major depression; application of the glucose clamp technique. Psychosom Med 70:170–176PubMedCrossRef

49.

Shaw K, Gennat H, O’Rourke P, Del Mar C (2006) Exercise for overweight or obesity. Cochrane Database Syst Rev CD003817

50.

Simon V, van Winkel R, De Hert M (2009) Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. J Clin Psychiatry 70:1041–1050PubMedCrossRef

51.

Skilton MR, Moulin P, Terra JL, Bonnet F (2007) Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 62:1251–1257PubMedCrossRef

52.

Skodol AE, Grilo CM, Pagano ME, Bender DS, Gunderson JG, Shea MT, Yen S, Zanarini MC, McGlashan TH (2005) Effects of personality disorders on functioning and well-being in major depressive disorder. J Psychiatr Pract 11:363–368PubMedCrossRef

53.

Skodol AE, Pagano ME, Bender DS, Shea MT, Gunderson JG, Yen S, Stout RL, Morey LC, Sanislow CA, Grilo CM, Zanarini MC, McGlashan TH (2005) Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychol Med 35:443–451PubMedCrossRef

54.

Vancampfort D, De Hert M, Skjerven LH, Gyllensten AL, Parker A, Mulders N, Nyboe L, Spencer F, Probst M (2012) International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia. Disabil Rehabil 34:1–12PubMedCrossRef

Titel: Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study
verfasst von: Kai G. Kahl
Wiebke Greggersen
Ulrich Schweiger
Joachim Cordes
Christoph U. Correll
Helge Frieling
Chakrapani Balijepalli
Christian Lösch
Susanne Moebus
Publikationsdatum: 01.04.2013
Verlag: Springer-Verlag
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 3/2013
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-012-0339-2

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Experience of social discrimination correlates with neurometabolism: a pilot study in heroin addicts

Risk genes, metabolic syndrome and eye tracking deficits in psychiatric diseases

Perceived patient–parent relationships and neural representation of parents in schizophrenia

Impaired volitional saccade control: first evidence for a new candidate endophenotype in obsessive–compulsive disorder

Single-subject classification of schizophrenia using event-related potentials obtained during auditory and visual oddball paradigms

Relationship between apolipoprotein E4 genotype and white matter integrity in HIV-positive young adults in South Africa

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie